Allergy Therapeutics (AGY)

Advertisement

Just one of over 6000 shares you can deal on with IG. Find out more by getting your free guide to spread betting on shares. Losses can exceed your initial deposit

 10.13p
   
  • Change Today:
      0.000p
  • 52 Week High: 13.50p
  • 52 Week Low: 7.63p
  • Currency: UK Pounds
  • Shares Issued: 409.87m
  • Volume: 0
  • Market Cap: £41.50m
  • RiskGrade: 90
  • Beta: 0.61

AGY Overview

Allergy Therapeutics is in the pharmaceuticals & biotechnology sector and is currently trading at 10.13p per share. In the last year Allergy Therapeutics's share price has ranged from 7.63p to 13.50p and brokers are currently rating this stock as 'buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 2.6% 4.4%
ROCE 9.1%  
Latest F'cast
P/E 40.5 25.3
PEG n/a 0.4
Pr/Revenue 1.0 1.0
Pr/Book 2.8  
Latest F'cast
Revenue -0.7% 0.2%
PBT n/a 181.2%
EPS n/a 60.0%
DPS n/a n/a

AGY Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-08 31.02 (20.24) (24.80)p n/a n/a n/a n/a 0.0%
30-Jun-09 37.76 (11.44) (14.35)p n/a n/a n/a n/a 0.0%
30-Jun-10 40.75 (0.12) 0.20p 57.5 n/a n/a n/a 0.0%
30-Jun-11 41.55 (2.31) (0.86)p n/a n/a n/a n/a 0.0%
30-Jun-12 41.28 0.64 0.25p 31.0 n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AGY Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-13 41.35 1.80 0.40p 25.3 0.4 +60% n/a 0.0%
30-Jun-14 44.35 2.85 0.55p 18.4 0.5 +38% n/a 0.0%

Copyright © 2013 FactSet Research Systems Inc. All rights reserved.

AGY Company Announcements

Grant of Options 15-May-2013 10:20 RNS
Holding(s) in Company 08-May-2013 10:39 RNS
Holding(s) in Company 08-May-2013 10:18 RNS

AGY ShareCast News

Allergy Therapeutics ends contract with Lincoln ... 27-Dec-2012 ShareCast
Chamberlin Chairman invests 75k 10-Dec-2012 ShareCast
Shanks Chairman buys shares as profits fall 09-Nov-2012 ShareCast

AGY Top Newspaper Links

Allergy drug firm hit by trials setback 12-Jul-2007 The Independent
Need to Know: Global Business Briefing 25-Mar-2006 Times

Latest AGY Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

AGY Market Data

Currency UK Pounds
Share Price 10.13p
Change Today 0.000p
% Change 0.00 %
52 Week High 13.50p
52 Week Low 7.63p
Volume 0
Shares Issued 409.87m
Market Cap £41.50m
Beta 0.61
RiskGrade 90

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
76.37% below the market average76.37% below the market average76.37% below the market average76.37% below the market average76.37% below the market average
17.39% below the sector average17.39% below the sector average17.39% below the sector average17.39% below the sector average17.39% below the sector average
Price Trend
36.24% below the market average36.24% below the market average36.24% below the market average36.24% below the market average36.24% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average
Income Not Available
Growth
27.6% below the market average27.6% below the market average27.6% below the market average27.6% below the market average27.6% below the market average
38.46% below the sector average38.46% below the sector average38.46% below the sector average38.46% below the sector average38.46% below the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AGY Dividends

No dividends found

Trades for --2013

Time Volume / Share Price
0 @ 0.000p

AGY Key Personnel

Finance Director Ian D Postlewaite
CEO Manuel Llobet

Top of Page